HAE vs. MMSI, ICUI, INSP, GKOS, STVN, AXNX, PRCT, IRTC, TNDM, and NARI
Should you be buying Haemonetics stock or one of its competitors? The main competitors of Haemonetics include Merit Medical Systems (MMSI), ICU Medical (ICUI), Inspire Medical Systems (INSP), Glaukos (GKOS), Stevanato Group (STVN), Axonics (AXNX), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Tandem Diabetes Care (TNDM), and Inari Medical (NARI). These companies are all part of the "surgical & medical instruments" industry.
Merit Medical Systems (NASDAQ:MMSI) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.
99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by insiders. Comparatively, 1.8% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Merit Medical Systems has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500.
Merit Medical Systems presently has a consensus target price of $92.78, indicating a potential upside of 13.30%. Haemonetics has a consensus target price of $108.67, indicating a potential upside of 13.51%. Given Merit Medical Systems' higher probable upside, analysts clearly believe Haemonetics is more favorable than Merit Medical Systems.
In the previous week, Haemonetics had 10 more articles in the media than Merit Medical Systems. MarketBeat recorded 19 mentions for Haemonetics and 9 mentions for Merit Medical Systems. Haemonetics' average media sentiment score of 1.02 beat Merit Medical Systems' score of 0.56 indicating that Merit Medical Systems is being referred to more favorably in the media.
Haemonetics has higher revenue and earnings than Merit Medical Systems. Haemonetics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
Haemonetics has a net margin of 8.98% compared to Haemonetics' net margin of 7.94%. Merit Medical Systems' return on equity of 22.25% beat Haemonetics' return on equity.
Merit Medical Systems received 29 more outperform votes than Haemonetics when rated by MarketBeat users. Likewise, 68.90% of users gave Merit Medical Systems an outperform vote while only 60.89% of users gave Haemonetics an outperform vote.
Summary
Merit Medical Systems and Haemonetics tied by winning 9 of the 18 factors compared between the two stocks.
Get Haemonetics News Delivered to You Automatically
Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HAE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Haemonetics Competitors List
Related Companies and Tools
